Stocklytics Platform

Income Statement

publish
The Stocklytics Income Statement Screener empowers investors to focus on companies with strong financial fundamentals. Whether you’re interested in growth, profitability, or overall revenue strength, this tool helps you make informed decisions.
name
arrow_downwardRevenue Price $ Change % Change Revenue Growth % Gross Profit Operating Income Net Income EBITDA EPS Diluted
Asset logo for symbol FORR
FORRForrester Research
_$16.52$0.14arrow_drop_up0.85%-$255.88M$6.76M$3.05M$45.34M-0.35AI Analysis
Asset logo for symbol ZEPP
ZEPPZepp Health Corporation
_$2.63-$0.46arrow_drop_down14.69%-$657.77M-$207.10M-$212.11M-$14.62M-1.64AI Analysis
AIZN
AIZNAssurant, Inc. 5.25% Subordinat
_$21.60-$0.44arrow_drop_down1.99%arrow_drop_up9.20%$11.13B$642.50M$642.50M$0.000.00AI Analysis
Asset logo for symbol CI
CICigna
_$322.50$0.16arrow_drop_up0.04%arrow_drop_up8.05%_$8.53B$5.16B$8.55B10.55AI Analysis
Asset logo for symbol TPST
TPSTTempest Therapeutics
_$0.86$0.02arrow_drop_up2.60%-_-$29.15M-$29.49M-$31.24M-1.46AI Analysis
Asset logo for symbol ACHL
ACHLAchilles Therapeutics plc
_$1.05-$0.00arrow_drop_down0.47%-_-$75.25M-$69.93M-$65.89M-1.59AI Analysis
Asset logo for symbol BMBL
BMBLBumble
_$7.82-$0.11arrow_drop_down1.38%arrow_drop_up16.41%$743.99M$53.37M-$4.21M$195.73M-4.72AI Analysis
Asset logo for symbol CHRW
CHRWCH Robinson Worldwide
_$109.08-$0.91arrow_drop_down0.82%-$1.15B$514.60M$325.12M$688.73M2.89AI Analysis
Asset logo for symbol MLYS
MLYSMineralys Therapeutics
_$12.86$1.45arrow_drop_up12.71%-_-$84.65M-$71.89M$0.00-3.31AI Analysis
Asset logo for symbol CCS
CCSCentury Communities
_$85.80$0.81arrow_drop_up0.95%-$853.74M$406.43M$259.22M$470.99M10.03AI Analysis
DRTS
DRTSWAlpha Tau Medical Ltd.
_$0.17-$0.02arrow_drop_down13.64%-_$35.68M-$29.15M-$35.22M0.00AI Analysis
Asset logo for symbol SFIX
SFIXStitch Fix
_$3.79$0.12arrow_drop_up3.40%-$592.03M-$133.42M-$118.88M-$38.47M-0.99AI Analysis
Asset logo for symbol ODP
ODPODP
_$25.81-$0.25arrow_drop_down0.95%-$1.76B$201.00M$139.00M$270.00M0.97AI Analysis
Asset logo for symbol KALV
KALVKalVista Pharmaceuticals
_$9.05-$0.26arrow_drop_down2.79%-_-$140.44M-$126.64M-$154.72M-3.57AI Analysis
Asset logo for symbol GSM
GSMFerroglobe PLC
_$4.49-$0.03arrow_drop_down0.77%-$391.35M$196.94M$82.66M$197.38M0.22AI Analysis
Asset logo for symbol HHS
HHSHarte-Hanks
_$6.00$0.04arrow_drop_up0.62%-$30.56M$3.35M-$1.57M-$27.83M-4.04AI Analysis
Asset logo for symbol TMC
TMCTMC the metals company
_$0.91-$0.04arrow_drop_down4.47%-_$72.38M-$73.78M-$90.37M-0.29AI Analysis
Asset logo for symbol DENN
DENNDenny's
_$6.26-$0.24arrow_drop_down3.69%arrow_drop_up1.64%$139.48M$52.82M$19.94M$77.86M0.33AI Analysis
Asset logo for symbol HDSN
HDSNHudson Technologies
_$5.76-$0.14arrow_drop_down2.37%-$111.50M$78.17M$52.24M$43.40M0.65AI Analysis
Asset logo for symbol DLTR
DLTRDollar Tree
_$64.87-$1.66arrow_drop_down2.49%arrow_drop_up8.01%$9.33B-$881.80M-$998.40M$1.02B-4.81AI Analysis
Showing 3741-3760 of 4977
Results per page:

Gain deeper insights into a company's earnings with the Stocklytics Income Statement Screener, designed to rank stocks in descending order of revenue. This tool allows you to quickly assess companies with the highest revenue and their overall income performance, providing key financial metrics for smarter investment decisions. Our screener offers detailed insights into the following income statement components: - Revenue Growth – Identify companies with impressive year-over-year growth, a critical indicator of potential future success. - Gross Profit – Analyze how well a company is managing its core production costs to generate profit. - Operating Income – Understand a company’s ability to generate profit from its primary operations, excluding non-operational activities. - Net Income – Examine the company's bottom line after all expenses, providing a clear picture of profitability. - EBITDA – Evaluate a company’s earnings before interest, taxes, depreciation, and amortization to get a sense of its overall profitability and operating performance. - EPS Diluted – Review earnings per share on a diluted basis, reflecting potential impacts of convertible securities and giving you a clearer picture of shareholder returns. By using the Stocklytics Income Statement Screener, you’ll have access to vital financial data that will help you evaluate a company's performance, profitability, and growth potential. Why the Income Statement Matters: - Revenue Performance: Understand which companies are excelling at generating top-line revenue. - Profitability: Analyze margins and earnings to identify financially strong companies. - Earnings Per Share: Evaluate companies with high earnings per share, a key metric for investors.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Take Your Investments to a Whole New Level